Labome.com, a Laboratory Reagents and Services Portal
January 11, 2010
Now Combines Biomedical Reagent Database and Reagent Application Database from ExactAntigen.com Labome.com, a laboratory reagents and services portal and search engine, now provides the best search capabilities to over 1 million biomedical laboratory reagents from over 60 high quality reagent providers, to over 1,500 laboratory services from 1,900 laboratory service providers, and to a huge [...]
WuXi AppTec and QIAGEN Enter into Partnership Agreement for Molecular Biomarker Development
January 10, 2010
SHANGHAI /PRNewswire-Asia/ -- WuXi AppTec Inc. today announced that it has entered into a partnership with QIAGEN to provide an integrated single solution for molecular biomarker development, validation and personalized healthcare targets to their respective client bases. QIAGEN will provide a complete portfolio of instrumentation, training, and consumables and WuXi AppTec will provide laboratory facilities [...]
Lab901 delivers first Next-generation RNA QC ScreenTape® System to Oxford Gene Technology
January 10, 2010
Edinburgh – Lab901 today announced that it has shipped the first of its next-generation ScreenTape® systems for automated RNA QC to Oxford Gene Technology (OGT) in Oxford, UK. ScreenTape R6K is a next-generation platform for RNA QC that automatically delivers the ScreenTape Degradation Value (SDV), an objective quality metric for total RNA samples. Lab901’s ScreenTape [...]
Caliper Licenses Microfluidics IP to Becton Dickinson
January 10, 2010
Litigation with HandyLab Settled HOPKINTON, Mass -- Caliper Life Sciences, Inc. (NASDAQ: CALP), a leading provider of life sciences tools, announced today that Becton, Dickinson and Company (BD), has acquired a license to Caliper’s microfluidics patent portfolio. “We are pleased that Becton Dickinson is leveraging the strength of our microfluidics intellectual property to facilitate the [...]
Stull, Stull & Brody Announces Investigation on Behalf of Shareholders of Zigo Corporation
January 8, 2010
NEW YORK--Attorney Advertising. Notice is hereby given that Stull, Stull & Brody has commenced an investigation on behalf of shareholders of the common stock of Zygo Corporation (“Zygo” or the “Company”) (Nasdaq: ZIGO - News) for possible breaches of fiduciary duty and other violations of state law by the Company’s Board of Directors in connection [...]
MarketLab Introduces Portable Centrifuge
January 8, 2010
Caledonia, MI --(PR.com)-- MarketLab announces the addition of the Portafuge E8 Centrifuge to its Spring 2010 Clinical Laboratory Catalog. The Portafuge is a portable, fixed-speed centrifuge (3300 rpm) designed to fit the needs of mobile medics and traveling lab technicians. This 12-volt unit can be plugged into any vehicle’s power outlet and offers quiet, vibration-free [...]
Beckman Coulter Genomics and the J. Craig Venter Institute Collaborate
January 8, 2010
Validation of the SPRIworks Fragment Library System I for the Illumina Genome Analyzer - Automated Process Enhances Speed and Reproducibility BREA, Calif. – Beckman Coulter, Inc. today announced a collaboration with the J. Craig Venter Institute (JCVI) on the validation of the SPRIworks Fragment Library System I for the Illumina* Genome Analyzer. The automated benchtop [...]
inXitu’s Cost Effective XRD Now Available for Clinker and Cement Analysis
January 8, 2010
Following the introduction of BTX in mid 2009, inXitu now offers a building materials version of this new class of products. Mountain View, CA --(PR.com)-- The challenge of using X-ray Diffraction for the analysis of clinker and cement has long been a challenge for the powder XRD industry. The complex nature of this application requires [...]
New Pre-Symptomatic Screening Test for Ovarian Cancer Coming From Arrayit Corporation
January 7, 2010
Major News Media Missed the Mark - Noninvasive Test Will Provide Hope for 90% of Women Diagnosed With This Silent Killer SUNNYVALE, CA--On December 9th, 2009, Arrayit Corporation (OTC.BB:ARYC - News), a leading manufacturer of products and services for disease prevention, treatment and cure, announced a breakthrough in ovarian cancer screening utilizing a microarray-based diagnostic [...]
454 Sequencing Study Uncovers Likely Culprit in Tasmanian Devil Transmissible Cancer
January 7, 2010
Tasmanian Devil project represents one of many ongoing wildlife management research studies to use high-throughput 454 Sequencing Systems to prevent devastation of earth’s diverse species and ecosystems. BRANFORD, Conn.--A study published in the journal, Science, reports that an international team of scientists has identified cells in the nervous system, called Schwann cells, to be the [...]

